Share on Facebook
Share on Twitter
Share on LinkedIn

Merck said it is recalling its combination cholesterol drug Liptruzet, which was introduced in May, because of packaging defects that could reduce effectiveness.

In a statement on its website, Whitehouse Station-based Merck said the recall will clear out the entire stock of Liptruzet, which includes all four dose strengths and every batch it has distributed.

Click here to read more.